Abstract
In order to study the relationship between dopamine (DA) and serotonin (5-HT) mechanisms in the caudate nucleus of cats, a behavioural analysis has been made of effects brought about by simultaneously or successively administered injections of DA, 5-HT, carbachol and some related compounds into the DA-sensitive caput nuclei caudati rostromedialis (CRM-area) and the 5-HT-sensitive caput nuclei caudati anteroventralis (CAV-area) in cats. The data reported here show that inhibition of the 5-HT activity in the CAV-area abolishes the effects elicited by activation of the DA mechanism in the CRM-area, and that inhibition of the DA mechanism in the CRM-area does not influence the effects elicited by inhibition of the 5-HT activity in the CAV-area. Furthermore, this study shows that inhibition of the cholinergic mechanism in the CAV-area abolishes the effects elicited by the activation of the DA mechanism in the CRM-area.
Finally, the experiments reveal that inhibition of the 5-HT mechanism in the CAV-area abolishes the effects elicited by activation of the cholinergic mechanism in the CAV-area, whereas inhibition of the cholinergic mechanism does not affect the effects elicited by activation of the 5-HT mechanism in this area.
A model by which these neurotransmitter systems might operate is proposed.
Similar content being viewed by others
References
Aghajanian, G. K., Kuhar, M. J., Roth, R. H.: Serotonin-containing neuronal perikarya and terminals: differential effects of p-chlorophenylalanine. Brain Res. 54, 85–101 (1973)
Arnfred, T., Randrup, A.: Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour. Acta pharmacol. (Kbh.) 26, 385–394 (1968)
Bartholini, G., Da Prada, M., Pletscher, A.: Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase. J. Pharm. Pharmacol. 20, 228–229 (1968)
Bartholini, G., Gey, K. F., Pletscher, A.: Enhancement of tyrosine transamination in vivo by catecholamines. Experientia (Basel) 26, 980–981 (1970)
Bartholini, G., Pletscher, A.: Atropine-induced changes of cerebral dopamine turnover. Experientia (Basel) 27, 1302–1303 (1971)
Cools, A., van Rossum, J. M.: Caudate dopamine and stereotyped behaviour of cats. Arch. int. Pharmacodyn. 197, 163–173 (1970)
Cools, A.: The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour. Arch. int. Pharmacodyn. 194, 259–269 (1971)
Cools, A.: The role of serotonin in the caudate nucleus: behavioural effects of intracaudate applied drugs in cats. Brain Res. 42, 539 (1972a)
Cools, A.: Athetoid and choreiform hyperkinesias produced by caudate application of dopamine in cats. Psychopharmacologia (Berl.) 25, 229–237 (1972b)
Cools, A.: The interdependency of electrically evoked effects and serotonin-induced behaviour: the inhibitory role of serotonin. In: The caudate nucleus and neurochemical control of behaviour, pp. 109–122. Thesis, Nijmegen 1973a
Cools, A.: Chemical and electrical stimulation of the caudate nucleus in freely moving cats: the role of dopamine. Brain Res. 58, 437–451 (1973b)
Cools, A.: Serotonin: a behaviourally active compound in the caudate nucleus of cats. J. Israeli med. Sci. 9, (Suppl.) 5–21 (1973c)
Grabowska, M., Antiewicz, L., Maj, J., Michala, K. J.: Apomorphine and central serotonin neurons. Pol. J. Pharm. Pharmacol. 25, 29 (1973)
Heller, A.: Neuronal control of brain serotonin. Fed. Proc. 31, 81–90 (1972)
Herz, A., ZieglgÄnsberger, W.: The influence of microelectrophoretically applied biogenic amines, cholinomimetics and procaine on synaptic excitation in the corpus striatum. Int. J. Neuropharmacol. 7, 221–230 (1968)
Hökfelt, T., Ungerstedt, U.: Electron and fluorscence microscopical studies on the nucleus caudatus putamen of the rat after unilateral lesions of ascending nigro-neostriatal dopamine neurons. Acta physiol. scand. 69, 415–426 (1969)
Jequier, E., Robinson, D., Lovenberg, W., Sjoerdsma, A.: Further studies on tryptophan hydroxylase in rat and beef pineal. Biochem. Pharmacol. 18, 1071–1081 (1969)
Klawans, H.: The pharmacology of parkinsonism. Dis. nerv. Syst. 29, 805–816 (1968)
Koe, B., Weissman, A.: p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. exp. Ther. 154, 499–576 (1966)
McGeer, P. L., McGeer, E. G., Fibiger, H., Wickson, V.: Neostriatal choline acetylase and cholinesterase following selective brain lesions. Brain Res. 35, 308–314 (1971)
McLennan, H., York, D.: Cholinergic mechanisms in the caudate nucleus. J. Physiol. (Lond.) 187, 163–175 (1966)
McLennan, H., York, D.: The action of dopamine on neurons of the caudate nucleus. J. Physiol. (Lond.) 189, 393–402 (1967)
Neill, D., Grossmann, S.: Behavioural effects of lesions or cholinergic blockade of the dorsal and ventral caudate of rats. J. comp. physiol. Psychol. 71, 311–317 (1970)
Ng, K. Y., Chase, T. N., Colburn, R. W., Kopin, I. O.: Dopamine: Stimulation-induced release from central neurons. Science 170, 481–489 (1970)
Parent, A., Poirier, L.: The medial forebrain bundle (MFB) and ascending monoaminergic pathways in the cat. Canad. J. Physiol. Pharmacol. 47, 781–785 (1969)
Pletscher, A.: Pharmacological changes of the dopamine metabolism in the basal ganglia. In: Psychotropic drugs and dysfunctions of the basal ganglia. G. E. Crane, R. Gardber, Eds., pp. 122–130. Public Health Service Publication no. 1938 (1969)
Scheel-Krüger, J.: Central effects of anticholinergic drugs measured by the apomorphine test in mice. Acta pharmacol. (Kbh.) 28, 1–16 (1970)
Snider, R., Niemer, W.: A stereotaxic atlas of the cat brain. London: University of Chicago Press 1964
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cools, A.R. The transsynaptic relationship between dopamine and serotonin in the caudate nucleus of cats. Psychopharmacologia 36, 17–28 (1974). https://doi.org/10.1007/BF00441378
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00441378